Literature DB >> 15449099

Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.

J P Hays1, K Eadie, R Veenhoven, C M Verduin, H Verbrugh, A van Belkum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15449099     DOI： 10.1007/s10096-004-1217-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children.

Authors:  B Wolf; M Kools-Sijmons; C Verduin; L C Rey; A Gama; J Roord; J Verhoef; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

2.  Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species.

Authors:  C M Verduin; M Kools-Sijmons; J van der Plas; J Vlooswijk; M Tromp; H van Dijk; J Banks; H Verbrugh; A van Belkum
Journal:  FEMS Microbiol Lett       Date:  2000-03-01       Impact factor: 2.742

3.  Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Authors:  C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; J Verhoef; H Van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Bacterial interference between pathogens in otitis media and alpha-haemolytic Streptococci analysed in an in vitro model.

Authors:  Krister Tano; Eva Grahn Håkansson; Stig E Holm; Sten Hellström
Journal:  Acta Otolaryngol       Date:  2002-01       Impact factor: 1.494

6.  Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.

Authors:  Reinier Veenhoven; Debby Bogaert; Cuno Uiterwaal; Carole Brouwer; Herma Kiezebrink; Jacob Bruin; Ed IJzerman; Peter Hermans; Ronald de Groot; Ben Zegers; Wietse Kuis; Ger Rijkers; Anne Schilder; Elisabeth Sanders
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

7.  Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age. Consequences for vaccine design?

Authors:  John P Hays; Cindy van der Schee; Anita Loogman; Kim Eadie; Cees Verduin; Howard Faden; Henri Verbrugh; Alex van Belkum
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

8.  Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.

Authors:  C Hol; C M Verduin; E E Van Dijke; J Verhoef; A Fleer; H van Dijk
Journal:  FEMS Immunol Med Microbiol       Date:  1995-06

9.  Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease.

Authors:  J P Hays; K Eadie; C M Verduin; J Hazelzet; H Verbrugh; A van Belkum
Journal:  J Med Microbiol       Date:  2003-09       Impact factor: 2.472
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.